Khan FR - Search Results

1

Cheminformatics-enhanced discovery of therapeutic agents targeting isocitrate lyase in Mycobacterium tuberculosis infections.

Alam A, Alqarni MH, Alotaibi BS, Khan FR, Alam MS, Aba Alkhayl FF, Alhafi AA, Almutairi TM, Alharbi ZM, Alshehri FF. Alam A, et al. Among authors: khan fr. J Biomol Struct Dyn. 2024 Sep 18:1-18. doi: 10.1080/07391102.2024.2404145. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 39295212

2

Unravelling the role of microneedles in drug delivery: Principle, perspectives, and practices.

Babu MR, Vishwas S, Khursheed R, Harish V, Sravani AB, Khan F, Alotaibi B, Binshaya A, Disouza J, Kumbhar PS, Patravale V, Gupta G, Loebenberg R, Arshad MF, Patel A, Patel S, Dua K, Singh SK. Babu MR, et al. Drug Deliv Transl Res. 2024 Jun;14(6):1393-1431. doi: 10.1007/s13346-023-01475-9. Epub 2023 Nov 30. Drug Deliv Transl Res. 2024. PMID: 38036849 Review.

3

Computational insights into overcoming resistance mechanisms in targeted therapies for advanced breast cancer: focus on EGFR and HER2 co-inhibition.

Abdulaziz O, Khan FR, Alharthi NS, Alhuthali HM, Hazazi A, Alzahrani HA, Gharib AF, Alsalmi OA, Hawsawi NM, Alhazmi AY. Abdulaziz O, et al. Among authors: khan fr. J Biomol Struct Dyn. 2024 Jan 17:1-12. doi: 10.1080/07391102.2024.2301766. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38234016

4

In silico assessment of a natural small molecule as an inhibitor of programmed death ligand 1 for cancer immunotherapy: a computational approach.

Alharthi NS, Alwethaynani MS, Alhazmi AY, Alawam AS, Alshehri FF, Alotaibi F, Rehman ZU, Alkhayl FFA, Al-Bazi MM, Khan FR. Alharthi NS, et al. Among authors: khan fr. J Biomol Struct Dyn. 2024 Feb 22:1-21. doi: 10.1080/07391102.2024.2317980. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38385444

5

Structural and energetic analysis of NS5 protein inhibition by small molecules in Japanese encephalitis virus using machine learning and steered molecular dynamics approach.

Alhazmi AY, Khan FR, Rehman ZU, Hazazi A, Alotaibi BS, Alharthi NS, Alhuthali HM, Aba Alkhayl FF, Alshehri FF, Alkhoshaiban A, Al-Otaibi F. Alhazmi AY, et al. Among authors: khan fr. J Biomol Struct Dyn. 2024 Feb 26:1-18. doi: 10.1080/07391102.2024.2316767. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38407246

6

Sakuranetin ameliorates streptozotocin-induced diabetes in rodents by inhibiting caspase-3 activity, modulating hematological parameters, and suppressing inflammatory cytokines: a molecular docking and dynamics study.

Almasoudi HH, Nahari MH, Binshaya AS, Hakami MA, Alhazmi AY, Al Shmrany H, Alqasem A, Khan FR. Almasoudi HH, et al. Among authors: khan fr. J Biomol Struct Dyn. 2024 Mar 9:1-18. doi: 10.1080/07391102.2024.2325659. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38459941

7

Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies.

Hakami MA, Khan FR, Abdulaziz O, Alshaghdali K, Hazazi A, Aleissi AF, Abalkhail A, Alotaibi BS, Alhazmi AYM, Kukreti N, Binshaya AS. Hakami MA, et al. Among authors: khan fr. Rev Med Virol. 2024 Jul;34(4):e2554. doi: 10.1002/rmv.2554. Rev Med Virol. 2024. PMID: 38862398 Review.

8

Signaling pathways in HPV-induced cervical cancer: Exploring the therapeutic promise of RNA modulation.

Hazazi A, Khan FR, Albloui F, Arif S, Abdulaziz O, Alhomrani M, Sindi AAA, Abu-Alghayth MH, Abalkhail A, Nassar SA, Binshaya AS. Hazazi A, et al. Among authors: khan fr. Pathol Res Pract. 2024 Sep 25;263:155612. doi: 10.1016/j.prp.2024.155612. Online ahead of print. Pathol Res Pract. 2024. PMID: 39357186 Review.

9

PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities.

Hakami MA, Hazazi A, Khan FR, Abdulaziz O, Alshaghdali K, Abalkhail A, Nassar SA, Omar BIA, Almarshadi F, Gupta G, Binshaya AS. Hakami MA, et al. Among authors: khan fr. Pathol Res Pract. 2024 Jan;253:155019. doi: 10.1016/j.prp.2023.155019. Epub 2023 Dec 7. Pathol Res Pract. 2024. PMID: 38091883 Review.

10

Non-coding RNAs and estrogen receptor signaling in breast cancer: Nanotechnology-based therapeutic approaches.

Ali AA, Belali TM, Abu-Alghayth MH, Alyahyawi Y, Abalkhail A, Hazazi A, Nassar SA, Khan FR, Shmrany HA, Syed SM. Ali AA, et al. Among authors: khan fr. Pathol Res Pract. 2024 Aug 29;263:155568. doi: 10.1016/j.prp.2024.155568. Online ahead of print. Pathol Res Pract. 2024. PMID: 39288475 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters